Bo Zhao

Bo Zhao (Brigham and Women’s Hospital / Harvard Medical School, USA) –”NPC Epigenetic Landscapes and Super-Enhancers” Chromatin modifying enzymes are frequently altered in NPC (Lin D et al Nature Genetics 2014) exome-seq results Epigenetic changes are reversible and druggable Super-enhancers are recently discovered enhancers with (1). Extraordinarily wide and tall signals for H3K27ac, BRD4 etc […]

Bo Zhao Read More »

Rebecca Skalsky

Rebecca Skalsky (Oregon Health and Science University, USA)“Regulation of Host Signaling Pathways by EBV miRNAs” EBV encodes 25 precursor miRNAs ~100-200 different target sites on mRNAs> 44 EBV miRNAs =significan tregulatory potential MiRNAs are great toools for viruses:– non-immunogenicity– -require limited encoding capacity (only 22 not)-can rapidly evolve; have Lymphocryptoivirus muRNAs are highly conserves Circular

Rebecca Skalsky Read More »

Bill Sugden

Bill Sugden (McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, USA) “How EBV Prevails During Productive Infection” Hybrid of P3HR1 and D98. (Endogenous P3HR1 cells) EBV’s lyticv phase commandeers the cell much as do a-herpesviruses Determining when vEBV DNA amplifies following induction off the productive cycle (treated cells with tamoxifen —> BZLF 1 expression) Tamoxifen was

Bill Sugden Read More »

Paul Farrell

Paul Farrell (Imperial College London, United Kingdom) –”EBV Genome Sequence Variation: Geography, Function and Disease” J Virol. 2017 Jul 12;91(15). Natural Variation of Epstein-Barr Virus Genes, Proteins, and Primary MicroRNA.   (PubMed Link) 138 new EBV genomes, 125 of these combined with 116 others = 241 Analysis of 241 aligned EBV genomes in multiple sequence alignment Type1/Type2

Paul Farrell Read More »

Irving Weissman

Irving Weissman (Stanford University School of Medicine, USA) “Normal and Neoplastic Stem Cells” Marrow or MPB (mobilized peripheral blood) Mixture of cells: HSCs, T cells, cancer cells Deplete mature blood cells by labeling with magnetic antibodies Pure HSCs for transplantation 250,000 fold depletion an ever cells or T cells Unwanted cells : cancer cells, T

Irving Weissman Read More »

Patrick Moore

Patrick Moore (University of Pittsburgh, USA)  “Why Do Viruses Cause Cancer?” PubMed Link (pdf 2803) Viruses do not “mean” to cause cancer • Cancer endangers virus as well as host • Viruses non-transmissible in tumors (eg latency, pseudo-latency) • Virus populations Limited resource hypothesis: enhancing lyric virus replication tumor virus targets at G1 phase Infection is

Patrick Moore Read More »

0621-0622 大會報告

Day 1院長致詞: 十一月份還會有一個retreat Emerging Trends and Opportunities for Microbiota Research高承源副研究員 (免疫醫學中心)– Microbiota is not just about bacteria, viruses, fungi are also included.– Analytic tools of microbiota (e.g.assembling the human gut Microbiota in metabolic diseases. – 16S/26S RNA sequencing)– Metaproteomics workflow– Models for human microbiota research– Organ-on-a-chip RootChip (different levels of oxygen at different layers of

0621-0622 大會報告 Read More »

Scroll to Top